Milestone Pharmaceuticals Inc.

NasdaqGS:MIST 株式レポート

時価総額:US$92.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Milestone Pharmaceuticals マネジメント

マネジメント 基準チェック /34

Milestone Pharmaceuticals'の CEO はJoe Olivetoで、 Mar2017年に任命され、 の在任期間は 7.25年です。 の年間総報酬は$ 1.98Mで、 30.4%給与と69.6%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.43%を直接所有しており、その価値は$ 396.40K 。経営陣と取締役会の平均在任期間はそれぞれ4年と6年です。

主要情報

Joe Oliveto

最高経営責任者

US$2.0m

報酬総額

CEO給与比率30.4%
CEO在任期間7.3yrs
CEOの所有権0.4%
経営陣の平均在職期間4yrs
取締役会の平均在任期間6yrs

経営陣の近況

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Recent updates

Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Jun 07
Here's Why Shareholders Should Examine Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) CEO Compensation Package More Closely

Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

Sep 13
Is Milestone Pharmaceuticals (NASDAQ:MIST) A Risky Investment?

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Mar 07
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

Oct 15
We're Keeping An Eye On Milestone Pharmaceuticals' (NASDAQ:MIST) Cash Burn Rate

We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

Jun 24
We Think Milestone Pharmaceuticals (NASDAQ:MIST) Can Afford To Drive Business Growth

We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

Feb 25
We're Hopeful That Milestone Pharmaceuticals (NASDAQ:MIST) Will Use Its Cash Wisely

We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Aug 25
We're Interested To See How Milestone Pharmaceuticals (NASDAQ:MIST) Uses Its Cash Hoard To Grow

Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

Apr 02
Companies Like Milestone Pharmaceuticals (NASDAQ:MIST) Are In A Position To Invest In Growth

What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

Jan 15
What You Need To Know About Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) Investor Composition

First patient enrolled in Milestone Pharmaceuticals' late-stage study of etripamil in PSVT

Nov 18

Milestone Pharmaceuticals EPS beats by $0.09

Nov 13

CEO報酬分析

Milestone Pharmaceuticals の収益と比較して、Joe Oliveto の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$2mUS$602k

-US$60m

Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$59m

Mar 31 2023n/an/a

-US$59m

Dec 31 2022US$3mUS$584k

-US$58m

Sep 30 2022n/an/a

-US$62m

Jun 30 2022n/an/a

-US$62m

Mar 31 2022n/an/a

-US$44m

Dec 31 2021US$4mUS$509k

-US$43m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$32m

Mar 31 2021n/an/a

-US$46m

Dec 31 2020US$4mUS$470k

-US$50m

Sep 30 2020n/an/a

-US$60m

Jun 30 2020n/an/a

-US$60m

Mar 31 2020n/an/a

-US$61m

Dec 31 2019US$785kUS$458k

-US$55m

Sep 30 2019n/an/a

-US$47m

Jun 30 2019n/an/a

-US$40m

Mar 31 2019n/an/a

-US$29m

Dec 31 2018US$1mUS$360k

-US$23m

Dec 31 2017US$851kUS$364k

-US$8m

報酬と市場: Joeの 総報酬 ($USD 1.98M ) は、 US市場 ($USD 678.50K ) の同規模の企業の平均を上回っています。

報酬と収益: Joeの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Joe Oliveto (56 yo)

7.3yrs

在職期間

US$1,978,092

報酬

Mr. Joseph G. Oliveto, also known as Joe, M.B.A. has been Chief Executive Officer and President of Milestone Pharmaceuticals Inc. March 2017 and has been its Director since July 2017. Mr. Oliveto served as...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Joseph Oliveto
CEO, President & Director7.3yrsUS$1.98m0.43%
$ 396.4k
Amit Hasija
CFO & Executive VP of Corporate Development4.8yrsUS$1.01m0.029%
$ 26.7k
David Bharucha
Chief Medical Officer2.3yrsUS$1.22m0.023%
$ 21.0k
Philippe Douville
Founderno dataデータなしデータなし
Jeffrey Nelson
Chief Operating Officer4yrsデータなしデータなし
Kim Fox
Vice President of Communicationsless than a yearデータなしデータなし
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Board4.4yrsデータなしデータなし
Guy Rousseau
SVP of Regulatory Affairs and Quality Managementno dataデータなしデータなし
Anita Holz
VP & Head of Medical Affairs1.8yrsデータなしデータなし

4.0yrs

平均在職期間

59yo

平均年齢

経験豊富な経営陣: MISTの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Joseph Oliveto
CEO, President & Director6.9yrsUS$1.98m0.43%
$ 396.4k
Philippe Douville
Founder4.4yrsデータなしデータなし
Philip Sager
Chief Medical Advisor & Member of the Scientific Advisory Boardno dataデータなしデータなし
Harry Leighton
Member of the Scientific Advisory Boardno dataデータなしデータなし
Daniel Omstead
Observer6.8yrsデータなしデータなし
Harry Kopelman
Member of the Scientific Advisory Boardno dataデータなしデータなし
Debra Liebert
Independent Non-Executive Director9yrsUS$149.27k0.015%
$ 14.1k
John DiMarco
Member of the Scientific Advisory Boardno dataデータなしデータなし
Paul Dorian
Member of the Scientific Advisory Boardno dataデータなしデータなし
Michael Tomsicek
Independent Non-Executive Director5.2yrsUS$153.27k0.023%
$ 20.8k
John Camm
Member of the Scientific Advisory Boardno dataデータなしデータなし
Robert Wills
Independent Chairman of the Board3.7yrsUS$176.77k0.023%
$ 20.8k

6.0yrs

平均在職期間

68yo

平均年齢

経験豊富なボード: MISTの 取締役会経験豊富 であると考えられます ( 6年の平均在任期間)。